Merck KGaA

Pharmalot… Pharmalittle… Welcome Back

Make a comment

Erbitux Prolongs Life In Lung Cancer Study

3 Comments

Genentech Faces Threat From New Erbitux Data

1 Comment

Pharmalot… Pharmalittle… Good Morning

Make a comment

Mylan: $6.7B for Merck KGaA Generic Biz

Make a comment

And Then There Were Three…Bidders

Make a comment

ImClone: Head And Neck Above The Rest

Make a comment

Ranbaxy: ‘We Are Not In A Rat Race’

1 Comment

$4 Billion! Do I Hear $5 Billion?

1 Comment

A Generic Frenzy?

Make a comment

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/